Pfizer announced: The coronavirus vaccine is no longer the company's biggest success.

In its second-quarter earnings report released on Tuesday, Pfizer reported results that exceeded analysts’ expectations, while also lowering the lower end of its annual revenue forecast. However, the management reduced its forecast for Covid-related revenue, according to CNBC.